XML 102 R65.htm IDEA: XBRL DOCUMENT v3.26.1
Segment Reporting - Summar of Segment Net Loss, Including Significant Segment Expenses (Details) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Research and development expenses:    
Research expenses $ 36,014,000 $ 12,659,000
Personnel-related (including stock-based compensation expense) 11,965,000 4,272,000
Facilities-related and other allocated costs 957,000 432,000
Total Research and development expenses 48,936,000 17,363,000
General and administrative 13,789,000 5,305,000
Credit loss - related party accounts receivable 0 117,000
Interest and dividend income (5,139,000) (2,414,000)
Unrealized losses on short-term investments 5,000 217,000
Net Loss $ (57,591,000) $ (20,588,000)